Kyverna Therapeutics (KYTX) Net Equity Issued and Repurchased (2023 - 2026)
Kyverna Therapeutics' (KYTX) quarterly Net Equity Issued and Repurchased came in at $34.8 million in Q3 2023.
Powered by 
Analysis
Kyverna Therapeutics (KYTX) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
Kyverna Therapeutics (KYTX) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $34.8 million in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Kyverna Therapeutics | 505.44 Mn | 505.44 Mn | - | 3.60 Mn |